72-h kinetics of high-sensitive troponin T and inflammatory markers after marathon

Johannes Scherr1, Siegmund Braun, Tibor Schuster

  • 1Department of Prevention and Sports Medicine, Klinikum rechts der Isar, Technische Universitaet Muenchen, Munich, Germany. scherr@sport.med.tum.de

Insights

Marathon running temporarily increases cardiac biomarkers like high-sensitive cardiac troponin T (hs-cTnT). These levels normalize within 72 hours, suggesting altered myocyte metabolism rather than cardiomyocyte necrosis.

Area of Science:

  • Exercise Physiology
  • Cardiovascular Research
  • Biomarker Analysis

Background:

  • Strenuous exercise, such as marathon running, elevates cardiac biomarkers.
  • The underlying cause of this elevation (e.g., cardiomyocyte necrosis vs. secondary mechanisms) remains unclear.

Purpose of the Study:

  • To investigate the kinetics of cardiac biomarkers, inflammation markers, and renal function following a marathon.
  • To determine if marathon-induced cardiac biomarker increases are indicative of cardiomyocyte necrosis.

Main Methods:

  • Measured high-sensitive cardiac troponin T (hs-cTnT), NT-proBNP, h-FABP, hs-CRP, IL-6, and cystatin C in 102 men before and after a marathon.
  • Assessed biomarker levels at 0, 24, and 72 hours post-race.

Main Results:

  • Cardiac biomarkers (hs-cTnT, NT-proBNP, h-FABP) peaked immediately post-marathon and returned to baseline within 72 hours.
  • Proinflammatory markers (IL-6, hs-CRP) and renal dysfunction (cystatin C) also increased post-race but were not correlated with hs-cTnT elevation.
  • Exercise intensity and training history did not correlate with hs-cTnT changes.

Conclusions:

  • The rapid normalization of cardiac biomarkers after marathon running suggests that cardiomyocyte necrosis is unlikely.
  • The observed biomarker kinetics may be explained by altered myocyte metabolism during strenuous exercise.
  • Further research into metabolic changes could elucidate the mechanisms behind exercise-induced cardiac biomarker elevations.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...